India Business News

Sign Up to Connect With Companies

  • Send Your Proposal & Company Profile.
  • Enhanced Filtered Search options.
  • Access & Download Database of the Companies.
  • CRM Access - Create & manage the leads & you can track the status.
  • View companies key figures details such as turnover, no of employees etc.
  • Create Account Already have an Account ? Login
img

-Randomized Phase 3 Clinical Trial with ADCETRIS Met Primary Endpoint, Demonstrating a Statistically Significant Improvement in Modified Progression-Free Survival- -Abstract to be Submitted for Presentation at the 2017 ASH Annual Meeting; Regulatory

img

Two recently-signed agreements will transfer Takeda’s measles and acellular pertussis vaccine technologies to India-based multi-national company Biological E. Limited (“BE”) to develop low-cost combination vaccines including diphth

img
GSMA

AT&T, China Mobile, China Unicom, China Telecom, Deutsche Telekom, Verizon and Vodafone Launch Mobile IoT (LPWA) Networks

img
SES

Primacom to double broadband speeds by efficiently leveraging SES Networks’ fully-managed Maritime+ service

img
QnA International

Indian Business Travel Market Value to Rise to USD 93 Billion by 2030

img
Rimini Street, Inc.

Respondents cite hybrid IT as a preferred strategy for leveraging current robust ECC release as foundational system of record; More than 50 percent of respondents estimate S/4HANA reimplementation costs between $10 and $100 million

img
NIIT Limited

Authored by:- Prof VS Rao, President, NIIT University

img
Ruchi Soya Industries Ltd.

Ruchi 'Saral Yoga' Abhiyaan integrates daily yoga sessions for employees into corporate routine

img
Sharp

Its ingenious air-purification technology validated to reduce airway inflammation in asthmatic patients

img
Racepoint Global

The firm makes strategic changes within as the agency continues to grow globally

img
WNS

First-of-its-kind Social Media Analytics Platform

img
Bionext

Helps companies accelerate the development of new medications by reducing the failure rate during the clinical phase